Remicade intravenous drip 100, manufactured by Mitsubishi Tanabe Pharma, contains infliximab (genetical recombination). This monoclonal antibody targets TNF-alpha and is used to treat various inflammatory conditions such as Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. It is provided as 100mg in 1 bottle with YJ code 2399402F1026.
Remicade intravenous drip 100
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →